Profile
Roland Andersson is the founder.
Mr. Andersson is the founder of Reccan AB, serving as Chairman since 2014.
Mr. Andersson is also the founder of Reccan Diagnostics AB. Mr. Andersson is currently the Director at Nordic Biotechnology AB and Foresight Pharma AB. Mr. Andersson is a Professor at the University of Lund since 2000.
Formerly, Mr. Andersson served as Independent Director at Lumito AB. Mr. Andersson earned a doctorate from the University of Lund.
Roland Andersson active positions
| Companies | Position | Start |
|---|---|---|
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Founder | - |
Nordic Biotechnology AB | Director/Board Member | - |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
Foresight Pharma AB | Director/Board Member | - |
Reccan AB
Reccan AB Medical SpecialtiesHealth Technology Develops blood tests for pancreatic cancer diagnosis | Founder | 01/01/2014 |
Former positions of Roland Andersson
| Companies | Position | End |
|---|---|---|
| LUMITO AB | Director/Board Member | - |
Training of Roland Andersson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumito AB
Lumito AB Medical SpecialtiesHealth Technology Develops, manufactures, and licenses imaging based on nanoparticles | Health Technology |
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Health Technology |
Nordic Biotechnology AB | |
Foresight Pharma AB | |
Reccan AB
Reccan AB Medical SpecialtiesHealth Technology Develops blood tests for pancreatic cancer diagnosis | Health Technology |
- Stock Market
- Insiders
- Roland Andersson
















